Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer

Journal of Histochemistry and Cytochemistry

Volumn 49, Issue 4, 2001, Pages 539-549

  Berberat, P O ^a   Friess, H ^a   Wang, L ^a   Zhu, Z ^a   Bley, T ^a   Frigeri, L ^a   Zimmermann, A ^a   Buchler M W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Galectins; Metastasis; Pancreas; Pancreatic carcinoma

Indexed keywords

GALECTIN; GALECTIN 3; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; METASTASIS; NORTHERN BLOTTING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; WESTERN BLOTTING;

EID: 0035075198     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540104900414     Document Type: Article

References (51)

1. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
2. Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family
3. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity
4. Galectins: A family of animal beta-galactoside-binding lectins
5. Crosslinking of mammalian lectin (galectin-1) by complex biantennary saccharides
6. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3
7. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system
8. Soluble galactoside-binding vertebrate lectins: A protein family with common properties
9. Decreased expression of galectin-3 is associated with progression of human breast cancer
10. Distribution of an endogenous beta-galactoside-specific lectin during foetal and neonatal rabbit development
11. Three soluble rat beta-galactoside-binding lectins
12. The Mac-2 antigen is a galactose-specific lectin that binds IgE
13. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism
14. LAMP-1 in CHO cells is a primary carrier of poly-N-acetyllactosamine chains and is bound preferentially by a mammalian S-type lectin
15. Invasion and metastasis in pancreatic cancer
16. Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases
17. Molecular aspects of pancreatic cancer and future perspectives
18. Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer
19. Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression
20. Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages
21. Expression of galectins in head and neck squamous cell carcinoma
22. Modulation of galectin-1 content in human head and neck squamous carcinoma cells by sodium butyrate
23. Evidence that a human soluble beta-galactoside-binding lectin is encoded by a family of genes
24. Cancer of the pancreas. 50 Years of surgery
25. KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers
26. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma
27. The galectin family of mammalian carbohydrate-binding molecules
28. Secretion of the galectin family of mammalian carbohydrate-binding proteins
29. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha
30. Ki-ras oncogene activation in preinvasive pancreatic cancer
31. Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas
32. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma
33. Presence of two signaling TGF-beta receptors in human pancreatic cancer correlates with advanced tumor stage
34. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties
35. Mechanisms of tumour metastasis
36. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells
37. Tissue fibronectin is an endogenous ligand for galectin-1
38. Cancer statistics, 1997
39. Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death
40. Apoptosis of T cells mediated by galectin-1
41. Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes
42. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression
43. Localization of galectin-3 in normal and diseased pancreatic tissue
44. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon
45. Galectin-3 is a nuclear matrix protein which binds RNA
46. Pancreatic carcinoma
47. General mechanisms of metastasis
48. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications
49. Expression of galectin-3 modulates T-cell growth and apoptosis
50. Adhesion molecules in tumor metastasis